Global Protein Engineering Market Research Report - Global Forecasting(2014-2020) - MarketsandMarkets

Share Article

New product launches and product development are the most preferred strategy adopted by key players in this market.



Key Players are Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.) and Waters Corp. (U.S), Agilent Technologies (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories Inc. (U.S.), Bruker Corp. (U.S.).

The global protein engineering market is poised to reach $1,463.0 million by 2020 from $610.3 million in 2014, at a CAGR of 15.7% from 2015 to 2020.

New product launches and product development are the most preferred strategy adopted by key players in this market. Players adopted these strategies to enhance their product offerings, increase their market share, cater to customers’ demands and consolidate their market presence.

Besides new product launches, agreement and partnership is the second most preferred strategies adopted by players in this market. Most of the pharmaceutical and biotechnology companies partnered with research institutes, universities and smaller market payers in order to hone the protein engineering technology and to gain market share in this market.

Further Inquiry on this Report @

The protein engineering market is dominated by established players such as Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories, Inc. (U.S.), AB-Sciex (U.S.) and Sigma-Aldrich Corp. (U.S.). These companies have a strong reputation and customer base.

Browse Related Report:
Protein Characterization and Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectroscopy), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery & Development), & by End Users - Global Forecast to 2019

Protein Expression Market by Products (Expression Vector, Service, Reagent), Application (Industrial, Therapeutic), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast) & by End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018

About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @

Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Visit our Blog @

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
since: 04/2009
Follow >
Market Research Report
since: 12/2010
Like >
Visit website